Olympiad Research LP Invests $259,000 in Bath & Body Works, Inc. $BBWI

Olympiad Research LP purchased a new stake in Bath & Body Works, Inc. (NYSE:BBWI) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 8,636 shares of the company’s stock, valued at approximately $259,000.

Several other institutional investors have also made changes to their positions in the stock. T. Rowe Price Investment Management Inc. increased its stake in Bath & Body Works by 7.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock worth $334,029,000 after acquiring an additional 781,681 shares during the period. Alliancebernstein L.P. lifted its position in shares of Bath & Body Works by 4.7% during the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company’s stock valued at $164,397,000 after acquiring an additional 243,611 shares during the period. AQR Capital Management LLC grew its holdings in shares of Bath & Body Works by 267.8% during the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock worth $121,073,000 after purchasing an additional 2,907,506 shares in the last quarter. GMT Capital Corp increased its position in shares of Bath & Body Works by 7.3% in the first quarter. GMT Capital Corp now owns 3,737,700 shares of the company’s stock worth $113,327,000 after purchasing an additional 255,600 shares during the period. Finally, Fuller & Thaler Asset Management Inc. raised its stake in Bath & Body Works by 115.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after purchasing an additional 1,973,679 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on BBWI. Wells Fargo & Company decreased their target price on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating on the stock in a report on Monday, October 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Jefferies Financial Group reduced their target price on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a report on Monday, October 13th. Barclays lowered their price target on Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a report on Monday, October 20th. Finally, Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday. Ten research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $38.18.

Bath & Body Works Stock Down 1.7%

Shares of BBWI stock opened at $22.03 on Friday. The firm has a market capitalization of $4.54 billion, a P/E ratio of 6.54, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a twelve month low of $21.71 and a twelve month high of $41.87. The stock’s fifty day simple moving average is $25.65 and its 200 day simple moving average is $28.61.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the previous year, the business posted $0.37 earnings per share. The business’s quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Friday, November 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 21st. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. Bath & Body Works’s payout ratio is currently 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.